Self-Tunable Engineered Yeast Probiotics limit dysbiosis
Animals undergoing Inflammatory Bowel Disease (IBD) model, TNBS-induced colitis, were treated with eATP-responsive synthetic yeast probiotics or control yeasts. Microbiome analysis revealed that self-tunable yeast probiotics suppressed intestinal inflammation and reduced intestinal dysbiosis